There are three education sessions specifically about multiple myeloma at the American Society of Clinical Oncology (ASCO) 2016 annual meeting. In addition, there is is an education session on immunotherapeutic approaches to hematologic malignancies which also may be of interest to attendees with a focus on multiple myeloma.

The multiple myeloma-specific sessions will take place the morning of Saturday, June 4, and during the afternoons on Sunday, June 5 and Monday, June 6.

The related session on immunotherapeutic approaches to hematologic malignancies takes place the afternoon of Friday, June 3.

In the education session information below, presentations are listed in the order they will be given within their session. Presentation titles are accompanied by the name of the presenter and, when available, a link to the accompanying article in the 2016 ASCO Education Book. The full text of each of these articles can be viewed online with no charge.

Links to PDF files containing the slides for each presentation will be added to this list as those files are made available to The Beacon courtesy of the ASCO presenters.

The Beacon also has similar lists of ASCO 2016 multiple myeloma-related oral presentations, poster presentations, and e-abstracts, as well as news articles about multiple myeloma at the ASCO 2016 meeting.

We want to thank the Beacon's sponsors for making it possible for The Beacon to provide this and other important news, information, and support to the multiple myeloma community worldwide.

#1 - T-Cell-Engaging Antibodies in Hematologic Malignancies

Presented by: Max S. Topp

#2 - Possible Roles of Checkpoint Inhibitors in Hematologic Malignancies

Presented by: Philippe Armand

#3 - Current Status of Cellular Therapy for the Treatment of Hematologic Malignancies

Presented by: Carl H. June

#4 - What We Have Not Heard About the Role of Immunotherapy in Hematologic Malignancies

Presented by: Veronika Bachanova

#1 - New Diagnostic and Staging Criteria in Myeloma

Presented by: S. Vincent Rajkumar
Accompanying article by S. Vincent Rajkumar

#2 - The Evolving Role of Imaging in Myeloma Diagnosis and Care

Presented by: Evangelos Terpos
Accompanying article by Evangelos Terpos, Meletios A. Dimopoulos, and Lia A. Moulopoulos

#3 - Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders

Presented by: Irene M. Ghobrial
Accompanying article by Salomon Manier, Karma Z. Salem, David Liu, and Irene M. Ghobrial

#1 - Optimal Duration and Choice of Maintenance

Presented by: Amrita Y. Krishnan

#2 - What Is Optimal Consolidation After Autologous Transplant?

Presented by: Ravi Vij

#3 - Is There a Role for Allogeneic Transplant in Multiple Myeloma?

Presented by: Parameswaran Hari

Article accompanying entire session by Amrita Krishnan, Ravi Vij, Jesse Keller, Binod Dhakal, and Parameswaran Hari

#1 - New Targets and New Agents in Multiple Myeloma

Presented by: Sagar Lonial
Accompanying article by Ajay K. Nooka and Sagar Lonial

#2 - New Sequencing Data and How It Can Be Used for Risk Stratification

Presented by: Nikhil C. Munshi
Accompanying article by  Raphael Szalat and Nikhil C. Munshi

#3 - MRD by NGS: Pros and Cons

Presented by: Herve Avet-Loiseau
Accompanying article by Herve Avet-Loiseau